mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |